Connect with us

Hi, what are you looking for?

Economy

Brazil says China ‘not transparent’ on vaccine

The Christ the Redeemer statue is lit up with the names of the victims of coronavirus disease (COVID-19) as it pays tribute to them in Rio de Janeiro, Brazil July 1, 2020. — REUTERS/PILAR OLIVARES

SAO PAULO — Brazil’s health regulator Anvisa said on Monday that China’s health authorities are not transparent in authorizing emergency use of coronavirus disease 2019 (COVID-19) vaccines, a statement that may further inflame political tension in the South American country.

Brazilian President Jair Bolsonaro, a consistent critic of China, has repeatedly cast doubt on the CoronaVac vaccine being developed by China’s Sinovac Biotech Ltd, saying its “origin” made it untrustworthy.

In Sao Paulo, Brazil’s most populous state, authorities have made a hard bet on the vaccine, with Governor Joao Doria, a Bolsonaro enemy, saying the state expected to start vaccinating its residents in January.

Sao Paulo will not be able to begin using the Sinovac vaccine until it is approved by Anvisa, however. While the health regulator has long been largely apolitical, Mr. Bolsonaro has been appointing allies to it in recent months, stoking fears among health professionals that its decisions may be affected by political considerations.

“Brazil is the international leader in the evaluation process for CoronaVac,” Anvisa said. “The vaccine has had an emergency use authorization in China since June of this year. The Chinese criteria for granting emergency use authorization are not transparent, and there is no available information about the criteria currently in use by Chinese authorities to make these decisions.”

At least tens of thousands of people have taken the Sinovac vaccine in China’s emergency use programme, officially launched in July, that targets limited groups of high-risk people.

Two candidates developed by units of state-backed Sinopharm are included in the programme.

China has not made public details of how it determines whether a novel coronavirus vaccine is qualified for emergency use. Its National Health Commission did not respond to a request for comment.

A Sinovac representative declined to comment but referred to a news conference in October at which a health official said the emergency inoculation was launched after stringent reviews and was in accordance with China’s laws and World Health Organization’s rules.

These vaccines showed “very good safety and immunogenicity readings in Phase 1 and Phase 2 clinical trials”, the official said.

CoronaVac is undergoing Phase 3 testing in Sao Paulo.

Doria said earlier on Monday that efficacy data would be released on Dec. 23, eight days later than initially planned, to allow for a larger sample size and more complete analysis. — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

Last Tuesday, I moderated the BusinessWorld insights panel entitled, “Saving, Spending, Investing: Achieving Financial Goals even amid a Crisis” with top financial advisors in the country –...

Economy

PearlPay, an all Filipino-led fintech company, took home the third prize during the global finals of the Visa Everywhere Initiative (VEI) last Sept. 15. Started in...

Economy

Follow us on Spotify BusinessWorld B-Side Despite saying that the pandemic response is a top priority, the executive department of the Duterte administration slashed the P50.4...

Economy

Wilcon Depot celebrates the successful opening of its newest retail store in Pila, Laguna, as part of its ongoing #FlyingHighTo100 store expansion campaign. Opened...

Economy

As climate change takes center stage as one of the world’s most pressing challenges, and countries race to transition from fossil fuels to clean energy...

Economy

Willis Towers Watson shares the secret to its successful 40 years of providing world-class advisory, broking services and business solutions The COVID-19 pandemic has...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Economy

US President Joseph R. Biden, Jr., will rely on ally countries to supply the bulk of the metals needed to build electric vehicles and focus on...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.



Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!